425: Strive & Semler Scientific Merger: Risks & Outlook

Strive and Semler Scientific detail risks and forward-looking statements regarding their proposed business combination.

Summary

• This Form 425 filing relates to the proposed business combination between Strive, Inc. and Semler Scientific, Inc.
• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, on November 10, 2025.
• The document contains cautionary statements regarding forward-looking statements, which include expectations about strategic and financial benefits, timing of closing, and successful integration of the combined businesses.
• Various risks associated with the merger are outlined, such as potential termination of the agreement, failure to close, legal proceedings, unrealized benefits (including those from Bitcoin treasury strategies), integration difficulties, unexpected costs, diversion of management attention, dilution, adverse customer/employee reactions, and changes in share price.
• Strive has filed a Registration Statement on Form S-4 with the SEC, which includes an information statement, proxy statement, and prospectus, to register Class A common stock to be issued in the transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus for important information about the companies and the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure for a proposed business combination, primarily outlining forward-looking statements and associated risks. It does not present financial results or operational updates that would typically drive a strong positive or negative sentiment. The sentiment is neutral as it informs about a significant corporate event and its potential challenges.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated positive impact on the combined company's future financial performance.
• Expected cost savings and strategic gains are projected from the proposed transaction.

Negatives

• The proposed transaction may not close when expected or at all due to conditions not being met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Dilution will occur for Strive's existing shareholders due to the issuance of additional Class A common stock.
• Potential for adverse reactions from customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• Any event, change, or circumstance could give rise to the right of one or both companies to terminate the merger agreement.
• The proposed transaction may not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized, partly due to changes in or problems arising from implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations and their enforcement could negatively impact the transaction.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities is a risk.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing could occur.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction. These include anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing of the proposed transaction, and the ability to successfully integrate the combined businesses. These statements are subject to inherent risks and uncertainties.

Management Comments

• Each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations.
• Strive and Semler Scientific undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

Industry Context

This filing is a standard regulatory disclosure for a proposed merger, common in industries undergoing consolidation or strategic shifts. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies, likely Semler Scientific given recent public statements, is involved in or planning to adopt a Bitcoin strategy. This positions the merger within a broader context of companies exploring digital asset integration and alternative treasury management strategies, a notable trend for some public companies.

Stakeholder Impact

• Shareholders of Strive and Semler Scientific face potential dilution from Strive's issuance of new shares and are urged to review proxy materials for voting decisions.
• Customers of both companies may experience adverse reactions or changes to business relationships.
• Employees of both companies may experience changes to their relationships or employment conditions.

Next Steps

• Strive and Semler Scientific will continue to work towards the closing of the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Recommendation

The filing primarily serves as a cautionary statement regarding forward-looking information and outlines various risks associated with the proposed business combination between Strive and Semler Scientific. While the merger itself is a significant event, this document does not provide new financial performance data or operational updates that would fundamentally alter an investment thesis. The emphasis on potential risks, including integration challenges, unrealized benefits, and dilution from share issuance, suggests a cautious approach. Investors should 'hold' and await the definitive Information Statement/Proxy Statement/Prospectus and further developments regarding the transaction's progress and terms before making a more definitive investment decision.

Keywords

Merger, Acquisition, Business Combination, Strive, Semler Scientific, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets